Tag Archives: RNA technology

Myeloid Therapeutics Rebrands as CREATE Medicines, Focused on Transforming Immunotherapy Through RNA-Based In Vivo Multi-Immune Programming

CREATE Medicines (“CREATE”) broadens clinical programs and capabilities to expand therapeutic potential and improve patient outcomes Therapies tolerably program immune cells inside the human body, providing clear differentiation among competitors and significant value potential for all stakeholders CREATE Medicines will … Read the full press release

GreenLight Biosciences Secures €35 Million EIB Loan to Develop Sustainable RNA-Based Pest Control Solutions

(IN BRIEF) GreenLight Biosciences has received a €35 million loan from the European Investment Bank (EIB) to advance its RNA-based biocontrol products, offering an alternative to chemical pesticides. This funding will support the company’s research and production efforts, with a … Read the full press release